Literature DB >> 25006194

Cell cycle inhibitors make progress.

Vicki Brower.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25006194     DOI： 10.1093/jnci/dju221

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

Review 1.  CDK6-a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation.

Authors:  A-S Tigan; F Bellutti; K Kollmann; G Tebb; V Sexl
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

2.  A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemia.

Authors:  Edison Ong; Anthony Szedlak; Yunyi Kang; Peyton Smith; Nicholas Smith; Madison McBride; Darren Finlay; Kristiina Vuori; James Mason; Edward D Ball; Carlo Piermarocchi; Giovanni Paternostro
Journal:  J Comput Biol       Date:  2015-04       Impact factor: 1.479

3.  Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt.

Authors:  Jinfang Zhang; Kai Xu; Pengda Liu; Yan Geng; Bin Wang; Wenjian Gan; Jianping Guo; Fei Wu; Y Rebecca Chin; Christian Berrios; Evan C Lien; Alex Toker; James A DeCaprio; Piotr Sicinski; Wenyi Wei
Journal:  Mol Cell       Date:  2016-05-26       Impact factor: 17.970

4.  Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells.

Authors:  Inge The; Suzan Ruijtenberg; Benjamin P Bouchet; Alba Cristobal; Martine B W Prinsen; Tim van Mourik; John Koreth; Huihong Xu; Albert J R Heck; Anna Akhmanova; Edwin Cuppen; Mike Boxem; Javier Muñoz; Sander van den Heuvel
Journal:  Nat Commun       Date:  2015-01-06       Impact factor: 14.919

5.  Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.

Authors:  Li Qin; Jianwei Chen; Dong Lu; Prashi Jain; Yang Yu; David Cardenas; Xiaohui Peng; Xiaobin Yu; Jianming Xu; Jin Wang; Bert W O'Malley; David M Lonard
Journal:  Endocr Relat Cancer       Date:  2021-08-13       Impact factor: 5.900

Review 6.  Targeting cell cycle regulators in hematologic malignancies.

Authors:  Eiman Aleem; Robert J Arceci
Journal:  Front Cell Dev Biol       Date:  2015-04-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.